Shilpa M. Somagond

Tetrazolylmethyl quinolines: Design, docking studies, synthesis, anticancer and antifungal analyses

Saba Kauser J. Shaikh, Ravindra R. Kamble, Shilpa M. Somagond et al. · European Journal of Medicinal Chemistry · 2017 · 49 citations

Medicinal Chemistry, Antifungal Agent, Engineering +8

Design, Docking, and Synthesis of Quinoline‐2 <i>H</i> ‐1,2,4‐triazol‐3(4 <i>H</i> )‐ones as Potent Anticancer and Antitubercular Agents

Shilpa M. Somagond, Ravindra R. Kamble, Pramod P. Kattimani et al. · ChemistrySelect · 2018 · 28 citations

Click chemistry based regioselective one‐pot synthesis of coumarin‐3‐yl‐methyl‐1,2,3‐triazolyl‐1,2,4‐triazol‐3(4<i>H</i>)‐ones as newer potent antitubercular agents

Shilpa M. Somagond, Ravindra R. Kamble, Praveen K. Bayannavar et al. · Archiv der Pharmazie · 2019 · 28 citations

Design, synthesis, docking and <i>in vitro</i> antifungal study of 1,2,4-triazole hybrids of 2-(aryloxy)quinolines

Shilpa M. Somagond, Ravindra R. Kamble, Pramod P. Kattimani et al. · Heterocyclic Communications · 2017 · 16 citations · Full text

Molecular Docking Studies, Medicinal Chemistry, 1,2,4-Triazole Moiety +13

Novel 5‐(1‐aryl‐1<i>H</i>‐pyrazol‐3‐yl)‐1<i>H</i>‐tetrazoles as glycogen phosphorylase inhibitors: An in vivo antihyperglycemic activity study

Pramod P. Kattimani, Shilpa M. Somagond, Praveen K. Bayannavar et al. · Drug Development Research · 2019 · 16 citations